Approvals/TGA/HOSPIRA LEVETIRACETAM CONCENTRATE FOR IV INFUSION levetiracetam 500 mg/5 mL concentrate for infusion vial

Approved

STANDARD

HOSPIRA LEVETIRACETAM CONCENTRATE FOR IV INFUSION levetiracetam 500 mg/5 mL concentrate for infusion vial

Pfizer Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: b9fb2c1be84993b8
Product Name: HOSPIRA LEVETIRACETAM CONCENTRATE FOR IV INFUSION levetiracetam 500 mg/5 mL concentrate for infusion vial
Artg Id: 211468
Artg Name: HOSPIRA LEVETIRACETAM CONCENTRATE FOR IV INFUSION levetiracetam 500 mg/5 mL concentrate for infusion vial
Sponsor: Pfizer Australia Pty Ltd
Company Detail Path: /organization/pfizer-australia-pty-ltd
Artg Date: 2014-07-28
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/02380c5b03645d8a2b379c6687e22628.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/dfa04533e4efabc4cbd4a5f67ba66c33.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

b9fb2c1be84993b8

Type

Standard